merck & co. - Search News

News

Merck, HPV vaccine and Robert F. Kennedy Jr.

RFK Jr.’s New Vaccine Panel Includes Two Paid Witnesses Against Merck

Two new vaccine advisers tapped by Health and Human Services Secretary Robert F. Kennedy Jr. have served as paid expert witnesses for plaintiffs suing Merck & Co. over some of the drug company’s inoculations targeting measles,

Benzinga · 13h

RFK Jr. Appointee To CDC Advisory Committee Was A Paid Expert In Merck's Gardasil Lawsuit

Martin Kulldorff, appointed by RFK Jr. to a federal vaccine panel, previously earned $33K as an expert witness in lawsuits targeting Merck's Gardasil vaccine.

Reuters on MSN · 13h

Exclusive: Kennedy's new vaccine adviser was expert witness against Merck vaccine

One of the new vaccine advisers picked by U.S. Health Secretary Robert F. Kennedy Jr. has earned thousands of dollars as an expert witness in litigation against Merck’s Gardasil vaccine, court records show.

11h

Merck & Co. Inc. stock outperforms competitors on strong trading day

Merck & Co. Inc. closed 39.23% short of its 52-week high of $134.63, which the company reached on June 25th.

1don MSN

Merck’s Cholesterol Medication Achieves Primary Endpoint in Two Trials

Merck & Co., Inc. (NYSE:MRK) is one of the best Dow stocks to invest in. On June 9, the company announced that its drug, ...

Fierce Biotech3d

Merck's leader in oral PCSK9 inhibitor race reduces cholesterol in pair of phase 3 trials

Merck & Co.’s ambition to get the first oral PCSK9 inhibitor to market came one step closer this morning as the pharma ...

Fierce Pharma3d

Feeling RSV heat from Merck, Sanofi lays out early supply plans for Beyfortus

One day before the potential FDA approval of a rival respiratory syncytial virus (RSV) monoclonal antibody from Merck & Co., ...

Merck & Co. Inc. stock underperforms Wednesday when compared to competitors

The stock's fall snapped a three-day winning streak.

Merck Wins US Approval for Shot to Prevent Infant RSV

Merck & Co. said it won US approval for a shot that protects against RSV, the most common cause of hospitalization among ...

Merck's Cholesterol Lowering Drug Hits Primary Goal In Two Pivotal Trials

Merck's oral PCSK9 inhibitor enlicitide showed significant LDL-C reductions in two Phase 3 trials, with no major safety ...

Merck & Co., Inc. (MRK) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

Merck & Co., Inc. ( NYSE: MRK) Goldman Sachs 46th Annual Global Healthcare Conference June 10, 2025 10:00 AM ET Dean Y. Li - Executive VP & President of Merck Research Laboratories Robert M. Davis - ...

BioPharma Dive3d

Merck claims study success with PCSK9 cholesterol pill

Enlicitide, which could be the first oral medication that blocks the protein PCSK9, helped cut cholesterol levels in a pair ...

InvestorsHub on MSN22h

Merck Launches Final-Stage Trial of Dengue Vaccine for Children

Merck & Co Inc (NYSE:MRK) has begun a Phase 3 clinical trial to test its experimental dengue vaccine in a pediatric ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results